Fluoxetine is used in the treatment of a variety of clinical disorders including depression and obesity, and of cocaine detoxification or alcoholism. It is generally believed that fluoxetine exerts its clinical effects because it selectively blocks 5-hydroxytryptamine (5HT) reuptake into nerve terminals. In here we describe that fluoxetine antagonized the neuronal homomeric ␣ 7 nicotinic acetylcholine receptors (nAChR) expressed in Xenopus oocytes, with an IC 50 of 43 M, when fluoxetine was coapplied with ACh, and of 1.6 M when the oocytes were pretreated briefly with fluoxetine. A similar block occurred in oocytes expressing L247T ␣ 7 mutant nAChR. Furthermore, blockage of mutant ␣ 7 receptors appeared non-competitive and was stronger with cell membrane hyperpolarization. Cell-attached single channel recordings in oocytes expressing L247T ␣ 7 mutant nAChR showed that the voltage-dependence of the blockage by fluoxetine could be due to a drastic decrease in channel opening frequency accompanied by marked channel flickering and reduced channel conductance. We conclude that fluoxetine behaves as a reversible blocker of both wild and mutant ␣ 7 receptors; and that the Leu-247T mutation in the channel domain renders the blockage of ␣ 7 nAChR by fluoxetine voltagedependent. These effects of fluoxetine on ␣ 7 receptors may be clinically important.
A great deal of interest has recently focused on the neuronal nicotinic ␣ 7 receptor due to its special structural and functional characteristics as compared to other members of the nicotinic receptor family. In particular, the ␣ 7 subunit forms functional homomeric receptors;
1,2 and the substitution of the conserved leucine 247 for threonine, in the M2 channel domain, changes drastically their function. [3] [4] [5] Fluoxetine is a potent inhibitor of 5HT uptake that is used extensively in clinical practice; and it was thought that its therapeutic effects were essentially due to blocking of the 5HT-transporter. 6 However, we have recently shown that fluoxetine is a potent blocker of nicotinic receptors, inhibiting not only heteromeric muscular but also neuronal nicotinic receptors expressed in Xenopus oocytes. 7 The experiments reported here were done in oocytes injected with ␣ 7 subunit cDNA to investigate whether fluoxetine would also block homomeric ␣ 7 nAChR. Fluoxetine was also used as a tool to investigate further the role of the Leu-247 residue as a determinant of the functional and pharmacological profiles of the ␣ 7 receptor.
Oocytes injected with the wild-type ␣ 7 subunit cDNA had a membrane potential of −38 ± 4 mV and responded to ACh with an inward current (I ACh ) whose peak amplitude depended on transmitter concentration. In oocytes held at −60 mV, 150 M ACh, a concentration close to the EC 50 for ␣ 7 nAChR, 1, [8] [9] [10] elicited a mean acetylcholine-current (I ACh ) of −77 ± 13 nA (mean ± sem n = 15; two donors, range −20 nA to −177 nA), that decayed to 90% (T 0.1 ) in 0.81 ± 0.01 s. Fluoxetine alone (100 M) did not elicit obvious current responses in either non-injected oocytes or oocytes expressing wild-type ␣ 7 nAChRs. Furthermore, in oocytes expressing wild-type ␣ 7 receptors the resting conductance (0.63 ± 0.27 S; five cells) was not altered significantly by fluoxetine. On the other hand fluoxetine, coapplied with ACh, reduced the amplitude of I ACh and its decay became slightly faster. Both parameters recovered promptly after fluoxetine was withdrawn. The inhibitory potency of fluoxetine increased as its concentration was increased. The mean fluoxetine dose-I ACh response relationship fitted to the Hill equation gave values for IC 50 and n H of 43 M and 1.1, respectively ( Figure 1 ). Increasing the concentration of fluoxetine from 1 M to 20 M changed the T 0.1 only 1.2-fold (see Figure 1) . Pretreatment with fluoxetine for 30 s increased considerably the blocking potency of fluoxetine, giving values for IC 50 and n H of 1.6 M and 1.0, respectively. As previously reported, 1,9 the I AChvoltage relation shows strong rectification at positive potentials. This pattern was not modified by fluoxetine (20 M) (eg Figure 2a) , indicating that the inhibitory action of fluoxetine on ␣ 7 nAChR function was not voltage-dependent.
It is known that the resting potential is lower and that the holding current required to clamp the cell is far greater for oocytes injected with the L247T ␣ 7 mutant than for those injected with ␣ 7 wild-type subunit cDNAs, due to the spontaneous activation of mutant nAChRs. 9, 11 Fluoxetine (100 M) applied alone to oocytes expressing L247T ␣ 7 nAChRs, showing a membrane potential of −24.7 ± 1.6 mV (13 oocytes; two donors), elicited an outward current of 60 ± 14 nA (I Fluox ; range 3-202 nA). I Fluox was accompanied by a change in resting conductance of −1.24 ± 0.24 S, suggesting that the positive current was caused by a reduction of an inward current rather than by activation of an outward current. In contrast, fluoxetine did not change the resting conductance in non-injected or injected but non-expressing oocytes. I Fluox inverted direction at −18.8 ± 1.4 mV, a value which is similar to the I ACh reversal potential; 9 I Fluox showed a time to peak of 5.87 ± 0.22 s and was maintained during fluoxetine perfusion (not shown). An equivalent outward current was observed when the oocytes were exposed to the potent competitive antagonist methyllycaconitine (MLA, 10 M) which also rapidly sup- pressed the I Fluox on the four oocytes tested (30-60 s; not shown). Accordingly, exposing the oocytes to fluoxetine (50-100 M) blocked the currents induced by MLA within 1-2 min of drug application (two oocytes, one donor). Altogether these observations suggest that fluoxetine, similarly to MLA, was blocking the resting current elicited by 'spontaneous' openings of the nicotinic receptor channels.
Oocytes injected with the L247T ␣ 7 mutant subunit cDNA responded to 0.2 M ACh with an I ACh whose peak amplitude (at −60 mV) averaged −1.2 ± 0.2 A (n = 48; six donors, range −122 nA to −6.2 A), and decayed with a T 0.1 Ͼ40 s. When fluoxetine was coapplied with ACh, the I ACh was reduced in amplitude and decayed faster, and both amplitude and time course recovered promptly after fluoxetine withdrawal. The blockage of I ACh by fluoxetine was again concentration-dependent, as illustrated in Figure 3 which shows the inhibition of I ACh elicited by 0.2 M ACh. The mean fluoxetine dose-I ACh response relationship fitted to Eqn 1 gave values of 16 M and 1.4, for IC 50 and n H respectively (21 oocytes; three donors). The inhibitory potency of fluoxetine was again clearly increased when the oocytes were pre-treated with fluoxetine for 30 s before applying ACh. This inhibitory potency was not further enhanced when the fluoxetine pre-treatment was prolonged to up to 2 h. With this procedure the IC 50 and n H were 8.5 M and 1.7, respectively (9 oocytes; two donors; see Figure 3 ). Moreover, fluoxetine significantly altered the current decay, in a dose-dependent manner (Figure 3, inset) and raising the fluoxetine concentration from 1 M to 20 M decreased T 0.1 an e-fold.
To investigate whether fluoxetine blocks the ␣ 7 mutant nAChR in a competitive manner, influencing its apparent affinity and cooperativity for the transmitter, ACh dose-I ACh response relationships were determined and compared to those obtained in the presence of fluoxetine. The mean dose-response curve, fitted to Eqn 2, gave values for EC 50 (0.21 M) and n H (1.4) matching those reported elsewhere. 4, 5 In the same oocytes, the EC 50 and n H values, 0.18 M and 1.7 respectively, were not significantly modified by the presence of fluoxetine at a concentration near the IC 50 value (data not shown). Considered together these findings indicate that the blockage of L247T ␣ 7 nAChR function by fluoxetine is not consistent with a competitive inhibition.
It is well established that in oocytes expressing L247T ␣ 7 nAChRs the I ACh -voltage relation is linear. 3, 4 In the presence of fluoxetine, the I ACh -voltage relation was still linear at positive potentials (five oocytes; two donors; eg Figure 2b ). In contrast, at negative membrane potentials (more negative than −60 mV), the I ACh was non-linearly related to the voltage and was considerably reduced at hyperpolarizing potentials, a finding consistent with a voltage-dependent channel block (Figure 2b) .
In order to see whether the behavior of the receptoractivated channels is compatible with a blockage of the channel by fluoxetine, experiments were performed in oocytes injected with L247T ␣ 7 subunit cDNA to compare, in different patches from the same oocyte, the single channel openings activated by ACh alone with those activated in the presence of fluoxetine. We have previously shown that oocytes expressing the ␣ 7 mutant receptor exhibit a fairly homogeneous population of ACh-activated channel openings in each oocyte. 12 In five oocytes (two donors) we found that, in the presence of fluoxetine: (i) channels exhibited a marked flickering; (ii) the channel slope conductance was linear but was reduced from 40-72 pS 12 to 20-27 pS; (ii) the open channel duration (range: 5-8 ms at +40 mV pipette potential) became considerably shorter (1-2 ms); and (iii) the frequency of openings, which increased in the controls, 12 was instead markedly reduced by hyperpolarization (Figure 4) .
Considered together, our findings show that fluoxetine inhibits the ␣ 7 wild-type and mutant nAChRs expressed in Xenopus oocytes. The action of fluoxetine, at least on the ␣ 7 mutant receptors, is non-competitive in nature and is presumably due mainly to a blockage of the open channels. This is suggested by: (i) the channel flickering activity; (ii) the shortening of the channel lifetime; (iii) the reduced channel conductance; (iv) the decrease in ACh-activated opening frequency with membrane hyperpolarization; (v) the fast I ACh decay; and (vi) the blockage of the spontaneous current in oocytes expressing ␣ 7 mutant nAChR and exposed to fluoxetine. The inhibitory action of fluoxetine becomes even more powerful when the oocytes are pre-incubated with fluoxetine, indicating that the action of ACh on ␣ 7 receptors is more potently inhibited after fluoxetine has interacted with the receptors. This could result from a slower rate of fluoxetine blocking action as compared to the fast activation of I ACh . Moreover, fluoxetine becomes more effective in blocking the activity of ␣ 7 mutant receptors, when the membrane is hyperpolarized. This results in a stronger effect on I ACh amplitude and on the rate of I ACh desensitization, compatible with an open channel blockade. Therefore, our findings show that mutation of the 'hydrophobic' conserved residue leucine into the 'polar' residue threonine in the channel domain renders the action of the blocker, fluoxetine, voltage-dependent.
Fluoxetine, one of the main drugs used for the treatment of depression, is a so-called 5-hydroxytryptamine-selective reuptake inhibitor. However, it has recently been shown that fluoxetine interferes with the function of various brain neurotransmitter receptors such as 5HT 1A , GABA B , 5HT 2C , dopamine and nicotinic receptors, 7, [13] [14] [15] suggesting that the mechanism of action of fluoxetine may be more complicated than previously thought. In here we show that fluoxetine is a potent blocker of the nicotinic ␣ 7 receptor which is extensively present in the nervous system. [16] [17] [18] Since the ␣ 7 receptors might be involved in schizophrenia, 19, 20 and the central nicotinic receptors may be involved in neurological disorders such as Alzheimer and Parkinson diseases, 21 our findings may help to design novel drugs for use in medical practice. Furthermore, it has been ascertained that the therapeutic plasma concentration of fluoxetine is in the micromo- lar range. 18 Thus, some of the therapeutic effects of fluoxetine may be a consequence of blocking both 5HT transporters and ␣ 7 receptors.
In conclusion, our findings refer fluoxetine as a drug clearly active on both muscular and neuronal nAChRs. This pleiotropic effect, which is common to a variety of antipsychotic drugs, complicates our understanding of their mode of action in the treatment of psychiatric disorders. Nevertheless, the actions of fluoxetine on ACh receptors and its clinical efficacy compared to that of other antipsychotic drugs, may provide insights on the functional role of central nicotinic receptors in neurological disorders.
Materials and methods

Oocyte injection
The cDNAs encoding the chick neuronal nAChR subunits were kindly provided by Dr Marc Ballivet. Full length cDNAs encoding wild-type ␣ 7 or L247T ␣ 7 neuronal nAChR subunits were expressed as previously described. 4, 9 Preparation of stage VI oocytes and nuclear injection procedures are detailed elsewhere.
22,23
Voltage-clamp recordings Membrane currents were recorded 2-4 days after injection, using a voltage-clamp technique with two microelectrodes filled with 3 M KCl. The oocytes were placed in a recording chamber (volume, 0.1 ml) perfused continuously with oocyte Ringer's medium (82.5 mM NaCl/2.5 mM KCl/2.5 mM CaCl 2 /1 mM MgCl 2 /5 mM Hepes/adjusted to pH 7.4 with NaOH) at room temperature (ෂ25°C), in the presence of atropine (1 M). Since atropine could affect the nicotinic response, in four oocytes (one donor) responses to ACh alone or to coapplications of ACh and fluoxetine were compared to those elicited without atropine. In all four oocytes atropine did not alter I ACh or the reduction of I ACh by fluoxetine.
To construct dose/response relationships, the oocyte membrane potential was held at −60 mV and the drugs were applied at 3-min intervals. After each determination, a control current was again elicited to check for possible current rundown. Drugs were dissolved in Ringer's and applied by superfusing the oocyte at a rate of 11 ml min −1
. Fluoxetine was usually coapplied with the neurotransmitter. Solution exchanges were achieved by using electromagnetic valves (Type III; General Valve, Fairfield, NJ, USA). Fluoxetine-HCl was purchased from Tocris (Bristol, UK) and dissolved just before the experiments, other drugs and chemicals were purchased from Sigma (Milan, Italy).
The current records were digitized at 50-150 Hz and stored in a computer for subsequent analysis, using pClamp 6.0.2 routines (Axon Instruments, Foster, CA, USA). To estimate the half-inhibitory concentration (IC 50 ) of fluoxetine, as well as the half dissociation constant (EC 50 ) of ACh, data were fitted, using least-square routines to Hill equations:
where [Fluox] and [ACh] are the drug concentrations, n H is the Hill coefficient, and I max is the maximum current response to ACh. The time to 10%-decay (T 0.1 ) of the ACh-induced inward current (I ACh ), defined as the time taken for the current to decay from its peak to 10%, was used to estimate the rate of receptor desensitization. For more details see Refs 4,9.
Cell-attached recordings
Single-channel currents were recorded from the animal pole of oocytes injected with L247T ␣ 7 subunit cDNA, using the patch-clamp technique in the cell-attached mode, as reported. 12, [24] [25] [26] Borosilicate-glass patch pipettes (2-4 M⍀ tip resistance) were filled with oocyte Ringer's medium containing ACh (0.2 M) or ACh (0.2 M) plus fluoxetine (10 M). Unitary channel activity was recorded using an Axopatch 200B amplifier (Axon Instruments). If no events were detected within 60 s after seal formation at 0-40 mV pipette potential, as well as when the frequency of openings was below 0.1 Hz, the patch was discarded. Typically, a successful patch was stable for 10-20 min and had Ͼ300 opening transitions. Current recordings were filtered at 2 kHz, sampled at 10 kHz and analyzed by pClamp 6.0.2 routines (Axon Instruments) using a threshold crossing criterion. Events briefer than 0.2 ms were incompletely resolved and were excluded from the open-time histograms, which thus represent apparent mean channel open-times. For each patch, slope conductances were obtained by least-squares linear fitting of current-voltage relations constructed by hyperpolarizing the patch potential up to 100 mV, and by depolarizing the patch membrane by up to 60 mV.
